Krill oil – hope or hype for the omega-3 market?
This content item was originally published on www.nutraingredients.com, a William Reed online publication.
![Krill oil – hope or hype for the omega-3 market?](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/2/2/1/2/282122-1-eng-GB/Krill-oil-hope-or-hype-for-the-omega-3-market.jpg)
At the recent FiE trade show in Frankfurt Dr Wael Massrieh, director of R&D at krill player Neptune Technologies & Bioressources, Adam Ismael, executive director of trade group GOED (Global Organisation for EPA and DHA Omega-3), and Robert Orr, CEO of fish oil player Ocean Nutrition Canada all give their views on krill oil.
A considerable number of studies already support the benefits of the omega-3 fatty acids eicosapentaenoic acid (EPA, C20:5 n-3) and docosahexaenoic acid (DHA, C22:6 n-3) for cardiovascular health, and cognitive health. Other areas of potential for the fatty acids include mood and behaviour, eye health, cancer risk reduction, and improved infant development.